Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 1, Pages 85
Publisher
MDPI AG
Online
2019-01-15
DOI
10.3390/cancers11010085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-β and Engagement of CD85j
- (2017) Sol Y. Nuñez et al. JOURNAL OF IMMUNOLOGY
- Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
- (2017) Tamara J. Abou-Antoun et al. Neurotherapeutics
- The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker
- (2017) Paul H. Krebsbach et al. STEM CELLS AND DEVELOPMENT
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
- (2017) Robert J. Canter et al. Journal for ImmunoTherapy of Cancer
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype
- (2016) Paola Infante et al. Cell Death & Disease
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
- (2016) Rossana Tallerico et al. Frontiers in Immunology
- Canine cancer immunotherapy studies: linking mouse and human
- (2016) Jiwon S. Park et al. Journal for ImmunoTherapy of Cancer
- Aldehyde dehydrogenases and cancer stem cells
- (2015) Xia Xu et al. CANCER LETTERS
- NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
- (2015) Erik Ames et al. JOURNAL OF IMMUNOLOGY
- The Role of Cytokines in Breast Cancer Development and Progression
- (2015) Marcela Esquivel-Velázquez et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells
- (2015) Erik Ames et al. OncoImmunology
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Consequences of the crosstalk between monocytes/macrophages and natural killer cells
- (2013) Tatiana Michel et al. Frontiers in Immunology
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
- (2012) Andreas Lundqvist et al. Journal of Cancer
- Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
- (2011) Isabel Barao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays
- (2011) Jintang He et al. MOLECULAR & CELLULAR PROTEOMICS
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma
- (2010) Shilpa Lingala et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-β1) in Patients with Gastric Cancer
- (2010) Andrzej Szkaradkiewicz et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
- (2010) Zeshaan A. Rasheed et al. JNCI-Journal of the National Cancer Institute
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition
- (2009) E. Ames et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Aldehyde dehydrogenase activity as a functional marker for lung cancer
- (2008) Deniz Ucar et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Direct and Natural Killer Cell-Mediated Antitumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma
- (2008) S. Armeanu et al. CLINICAL CANCER RESEARCH
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More